Search | IOVS | ARVO Journals

Showing 1 – 20 of 33

SORT: Best Match Most Recent Oldest

VIEW: Basic | Expanded

ARVO Annual Meeting Abstract June 2020

Real world evidence of retinal vein occlusion (RVO) patient treatment with ranibizumab in Germany based on the 24 months interim results of the non-interventional, observational PACIFIC study

Katrin Lorenz; Christos Haritoglou; Kristina Markova; Berenice Rösler; Matthias Iwersen; Ulrike Michel; Bianca Apitzsch; Hüsnü Berk; Christian Karl Brinkmann; Ramin Khoramnia; Martin Scheffler; Jens Schrecker; Gregor Schwert; Focke Ziemssen

Invest. Ophthalmol. Vis. Sci.. 2020; 61(7):1310. doi:

ARVO Annual Meeting Abstract June 2020

Evaluation of nanorobots for targeted delivery into the retina

Sven Schnichels; Rahul Goyal; José Hurst; Focke Ziemssen; Tian Qiu; Peer Fischer

Invest. Ophthalmol. Vis. Sci.. 2020; 61(7):1355. doi:

ARVO Annual Meeting Abstract June 2020

Sitagliptin does not stabilize a VEGF-A-challenged barrier of retinal endothelial cells

Heidrun L Deissler; Anja Jaeckle; Juergen Kampmeier; Gabriele E Lang; Focke Ziemssen

Invest. Ophthalmol. Vis. Sci.. 2020; 61(7):1753. doi:

ARVO Annual Meeting Abstract July 2019

Interdisciplinary Communication: Ophthalmologists’ letters to secondary diabetes care centers

Lydia Marahrens; Daniel Roeck; Andreas Fritsche; Focke Ziemssen

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):1091. doi:

ARVO Annual Meeting Abstract July 2019

Presenting characteristics: The spectrum and prevalence of self-reported pain in ocular emergencies in a tertiary center of Southeast Africa

Friederike Charlotte Kortuem; Constanze Ilse Kortuem; Esther Misango; Petros Kayange; Justus Benrath; Focke Ziemssen

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):2517. doi:

ARVO Annual Meeting Abstract July 2019

Observation of ranibizumab treatment in real-life conditions – an interim analysis of the myopic choroidal neovascularization (mCNV) population within the observational, non-interventional PACIFIC study

Kristina Markova; Christos Haritoglou; Matthias Iwersen; Ulrike Michel; Martina Junge; Peter Geuking; Katrin Lorenz; Thomas Ach; Ramin Khoramnia; Andreas Schmidt; Judith Becker; Erik Beeke; Mathias Müller-Holz; Daniel Barthelmes; Focke Ziemssen

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):4320. doi:

ARVO Annual Meeting Abstract July 2019

Presence and progression of atrophic areas in pathological myopia

Charlotte Anne Melzer; Focke Ziemssen; Nicole Eter; Christian Karl Brinkmann; Hansjürgen Agostini; Gisela Haeusser-Fruh; Uwe Rose; Marc Schargus; Katrin Lorenz; Frank G Holz; Steffen Schmitz-Valckenberg

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):4352. doi:

Articles December 2018

Combined Targeted Analysis of Metabolites and Proteins in Tear Fluid With Regard to Clinical Applications

PDF

Sascha Dammeier; Peter Martus; Franziska Klose; Michael Seid; Dario Bosch; Janina D‘Alvise; Focke Ziemssen; Spyridon Dimopoulos; Marius Ueffing
TAGS: metabolites, proteins, eye
Trans. Vis. Sci. Tech.. 2018; 7(6):22. doi: https://doi.org/10.1167/tvst.7.6.22

Includes: Supplemental Content

ARVO Annual Meeting Abstract July 2018

Interim results of the German diabetic macula edema (DME) population within the PACIFIC study

Kristina Markova; Christos Haritoglou; Matthias Iwersen; Ulrike Michel; Florian Diwischek; Matthias Grüb; Focke Ziemssen

Invest. Ophthalmol. Vis. Sci.. 2018; 59(9):3612. doi:

ARVO Annual Meeting Abstract July 2018

Reporting of safety events across anti-VEGF indications and the Pharmacovigilance approach: Findings from the non-interventional OCEAN study

Focke Ziemssen; Jessica Voegeler; Georg Spital; Sandra Liakopoulos; Steffen Schmitz-Valckenberg; Thomas Bertelmann

Invest. Ophthalmol. Vis. Sci.. 2018; 59(9):215. doi:

ARVO Annual Meeting Abstract July 2018

Red flags of diabetic retinopathy (DR) in patients with Type 1 Diabetes mellitus (T1DM) using HbA1c level and antihypertensive medication

Lydia Marahrens; Fritsche Andreas; Daniel Roeck; Focke Ziemssen

Invest. Ophthalmol. Vis. Sci.. 2018; 59(9):1042. doi:

ARVO Annual Meeting Abstract June 2017

Influence of OCT-examination during ranibizumab treatment of AMD patients in a real-life setting (OCEAN study)

Frederic Gunnemann; Jessica Voegeler; Steffen Schmitz-Valckenberg; Georg Spital; Sandra Liakopoulos; Focke Ziemssen

Invest. Ophthalmol. Vis. Sci.. 2017; 58(8):412. doi:

ARVO Annual Meeting Abstract June 2017

Challenges in Grading of Diabetic Retinopathy using Non-mydriatic Wide-field Imaging

Daniel Rock; Lydia Marahrens; Tjalf Ziemssen; Martin Leitritz; Clin Lucien; Focke Ziemssen

Invest. Ophthalmol. Vis. Sci.. 2017; 58(8):1880. doi:

ARVO Annual Meeting Abstract June 2017

Dependency of BCVA and ranibizumab treatment frequency of DME patients in a real-life setting (OCEAN study)

Focke Ziemssen; Jessica Voegeler; Steffen Schmitz-Valckenberg; Georg Spital; Sandra Liakopoulos

Invest. Ophthalmol. Vis. Sci.. 2017; 58(8):1904. doi:

ARVO Annual Meeting Abstract June 2017

Hurdles and Barriers of Eye screening and Interdisciplinary Exchange: lessons learned from the DiabCheck study

Lydia Marahrens; Daniel Röck; Tjalf Ziemssen; Andreas Fritsche; Focke Ziemssen

Invest. Ophthalmol. Vis. Sci.. 2017; 58(8):2907. doi:

ARVO Annual Meeting Abstract June 2017

Real-life effectiveness of Ranibizumab in RVO patients in a prospective, non-interventional trial over 12 months (OCEAN study)

Josep Callizo; Thomas Bertelmann; Jessica Voegeler; Steffen Schmitz-Valckenberg; Georg Spital; Nicolas Feltgen; Sandra Liakopoulos; Focke Ziemssen

Invest. Ophthalmol. Vis. Sci.. 2017; 58(8):3674. doi:

ARVO Annual Meeting Abstract June 2017

Baseline parameters of the HELP study (long-term observation of Caucasians with pathologic myopia): distribution of age in pre-defined risk categories for developing a myopic choroidal neovascularization

Charlotte Melzer; Focke Ziemssen; Nicole Eter; Christian Karl Brinkmann; Hansjuergen Agostini; Gisela Haeusser-Frueh; Schargus Marc; Katrin Lorenz; Frank G Holz; Steffen Schmitz-Valckenberg

Invest. Ophthalmol. Vis. Sci.. 2017; 58(8):5489. doi:

ARVO Annual Meeting Abstract September 2016

Comparison of optic nerve head analysis in patients with glaucomatous optic neuropathy between the simultaneous stereoscopic photography retinal camera (Kowa nonmyd WX3D) and the confocal scanning laser ophthalmoscope (HRT III)

Siegfried Mariacher; Stephanie Hipp; Robert Whirtky; Gunnar Blumenstock; Karl Ulrich Bartz-Schmidt; Focke Ziemssen; Ulrich Schiefer; Bogomil Voykov; Kai Januschowski

Invest. Ophthalmol. Vis. Sci.. 2016; 57(12):836. doi:

ARVO Annual Meeting Abstract September 2016

Prevalence of diabetic retinopathy in dependence on the steps of Diabetes Management Guidelines

Lydia Marahrens; Daniel Röck; Raimar Kern; Tjalf Ziemssen; Andreas Fritsche; Peter Martus; Focke Ziemssen

Invest. Ophthalmol. Vis. Sci.. 2016; 57(12):1597. doi:

ARVO Annual Meeting Abstract September 2016

Limitations of Retinal Thickness Analysis in Cross-Sectional Data

Daniel Rock; Lydia Marahrens; Raimar Kern; Tjalf Ziemssen; Andreas Fritsche; Focke Ziemssen

Invest. Ophthalmol. Vis. Sci.. 2016; 57(12):4264. doi:

1 2

Next 20 Results »

NARROW

Content Type

Journal

Article Type

Topics

Tags

Specify Date Range

Real world evidence of retinal vein occlusion (RVO) patient treatment with ranibizumab in Germany based on the 24 months interim results of the non-interventional, observational PACIFIC study

Evaluation of nanorobots for targeted delivery into the retina

Sitagliptin does not stabilize a VEGF-A-challenged barrier of retinal endothelial cells

Interdisciplinary Communication: Ophthalmologists’ letters to secondary diabetes care centers

Presenting characteristics: The spectrum and prevalence of self-reported pain in ocular emergencies in a tertiary center of Southeast Africa

Observation of ranibizumab treatment in real-life conditions – an interim analysis of the myopic choroidal neovascularization (mCNV) population within the observational, non-interventional PACIFIC study

Presence and progression of atrophic areas in pathological myopia

Combined Targeted Analysis of Metabolites and Proteins in Tear Fluid With Regard to Clinical Applications

Interim results of the German diabetic macula edema (DME) population within the PACIFIC study

Reporting of safety events across anti-VEGF indications and the Pharmacovigilance approach: Findings from the non-interventional OCEAN study

Red flags of diabetic retinopathy (DR) in patients with Type 1 Diabetes mellitus (T1DM) using HbA1c level and antihypertensive medication

Influence of OCT-examination during ranibizumab treatment of AMD patients in a real-life setting (OCEAN study)

Challenges in Grading of Diabetic Retinopathy using Non-mydriatic Wide-field Imaging

Dependency of BCVA and ranibizumab treatment frequency of DME patients in a real-life setting (OCEAN study)

Hurdles and Barriers of Eye screening and Interdisciplinary Exchange: lessons learned from the DiabCheck study

Real-life effectiveness of Ranibizumab in RVO patients in a prospective, non-interventional trial over 12 months (OCEAN study)

Baseline parameters of the HELP study (long-term observation of Caucasians with pathologic myopia): distribution of age in pre-defined risk categories for developing a myopic choroidal neovascularization

Comparison of optic nerve head analysis in patients with glaucomatous optic neuropathy between the simultaneous stereoscopic photography retinal camera (Kowa nonmyd WX3D) and the confocal scanning laser ophthalmoscope (HRT III)

Prevalence of diabetic retinopathy in dependence on the steps of Diabetes Management Guidelines

Limitations of Retinal Thickness Analysis in Cross-Sectional Data

To View More...

You must be signed into an individual account to use this feature.